Bionano Genomics
The San Diego-based firm also said it expects European customers to get optical genome mapping-based assays for leukemia and FSHD accredited.
Bionano Genomics Q1 Revenues Almost Triple
The San Diego-based optical genome mapping instrument maker saw record consumables revenue and beat Wall Street's consensus estimate on the top line.
Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics
Bionano Genomics called the study, presented this week at the American College for Medical Genetics meeting, an "incredibly important milestone" for the company.
The company is also working on a new Saphyr system that will have 14 times higher throughput than the current one, which can analyze 5,000 human genomes per year.
Mar 23, 2021
Bionano Genomics Q4 Revenues Grow 43 Percent
Nov 12, 2020
Bionano Genomics Q3 Revenues Down 33 Percent
Aug 17, 2020
Aug 13, 2020
Bionano Genomics Q2 Revenues Fall 46 Percent
Jun 19, 2020
Bionano Genomics Q1 Revenues Drop 39 Percent
Jun 15, 2020
Apr 2, 2020
Bionano Prices $18M Stock, Warrant Offering
Mar 5, 2020